Every SEC Form 3/4/5 on record for this filer (CIK 1542519) — 1 issuer, 35 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | Director | 2015-12-04 → 2026-05-28 | 31 | −$840,419 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ADMA | 2026-05-27 | Buy | 6,400 | $7.91 | $50,624 | 520,284 |
| ADMA | 2026-05-12 | Buy | 12,500 | $8.01 | $100,125 | 513,884 |
| ADMA | 2026-05-11 | Buy | 12,500 | $8.01 | $100,125 | 501,384 |
| ADMA | 2025-06-09 | Sell | 10,000 | $21.31 | $213,100 | 478,194 |
| ADMA | 2024-08-29 | Sell | 136,861 | $17.27 | $2M | 467,305 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.